Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Cottone

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
BMJ Supportive & Palliative Care|May 4, 2021
Fatigue in newly diagnosed acute myeloid leukaemia: general population comparison and predictive factorsLaura B Oswald, Adriano Venditti, David Cella, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 24, 2014
Randomized phase III trial of retinoic acid and arsenic trioxide versus retinoic acid and chemotherapy in patients with acute promyelocytic leukemia: health-related quality-of-life outcomesFabio Efficace, Franco Mandelli, Giuseppe Avvisati, et al.
The Lancet. Healthy Longevity|September 14, 2022
Association of IMWG frailty score with health-related quality of life profile of patients with relapsed refractory multiple myeloma in Italy and the UK: a GIMEMA, multicentre, cross-sectional studyFabio Efficace, Gianluca Gaidano, Maria Teresa Petrucci, et al.
The Lancet. Oncology|September 26, 2015
Prognostic value of self-reported fatigue on overall survival in patients with myelodysplastic syndromes: a multicentre, prospective, observational, cohort studyFabio Efficace, Gianluca Gaidano, Massimo Breccia, et al.
The Oncologist|May 11, 2025
Patient-reported outcomes from DESTINY-Breast04: trastuzumab deruxtecan versus physician's choice of chemotherapy in patients with HER2-low mBCNaoto T Ueno, Francesco Cottone, Kyle Dunton, et al.
BMJ Supportive & Palliative Care|September 11, 2014
Health-related quality of life in transfusion-dependent patients with myelodysplastic syndromes: a prospective study to assess the impact of iron chelation therapyFabio Efficace, Valeria Santini, Giorgio La Nasa, et al.
Leukemia|February 23, 2020
The IPSS-R more accurately captures fatigue severity of newly diagnosed patients with myelodysplastic syndromes compared with the IPSS indexFabio Efficace, Francesco Cottone, Laura B Oswald, et al.
Leukemia|September 4, 2019
Health-related quality of life of newly diagnosed chronic myeloid leukemia patients treated with first-line dasatinib versus imatinib therapyFabio Efficace, Fabio Stagno, Alessandra Iurlo, et al.
Cancer|October 6, 2023
Patient-reported symptom monitoring and adherence to therapy in patients with newly diagnosed chronic myeloid leukemiaFabio Efficace, Francesco Cottone, Betina Yanez, et al.
Cancer|December 13, 2017
Patient-reported outcomes enhance the survival prediction of traditional disease risk classifications: An international study in patients with myelodysplastic syndromesFabio Efficace, Francesco Cottone, Gregory Abel, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
BMJ Supportive & Palliative Care|May 4, 2021
Fatigue in newly diagnosed acute myeloid leukaemia: general population comparison and predictive factorsLaura B Oswald, Adriano Venditti, David Cella, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 24, 2014
Randomized phase III trial of retinoic acid and arsenic trioxide versus retinoic acid and chemotherapy in patients with acute promyelocytic leukemia: health-related quality-of-life outcomesFabio Efficace, Franco Mandelli, Giuseppe Avvisati, et al.
The Lancet. Healthy Longevity|September 14, 2022
Association of IMWG frailty score with health-related quality of life profile of patients with relapsed refractory multiple myeloma in Italy and the UK: a GIMEMA, multicentre, cross-sectional studyFabio Efficace, Gianluca Gaidano, Maria Teresa Petrucci, et al.
The Lancet. Oncology|September 26, 2015
Prognostic value of self-reported fatigue on overall survival in patients with myelodysplastic syndromes: a multicentre, prospective, observational, cohort studyFabio Efficace, Gianluca Gaidano, Massimo Breccia, et al.
The Oncologist|May 11, 2025
Patient-reported outcomes from DESTINY-Breast04: trastuzumab deruxtecan versus physician's choice of chemotherapy in patients with HER2-low mBCNaoto T Ueno, Francesco Cottone, Kyle Dunton, et al.
BMJ Supportive & Palliative Care|September 11, 2014
Health-related quality of life in transfusion-dependent patients with myelodysplastic syndromes: a prospective study to assess the impact of iron chelation therapyFabio Efficace, Valeria Santini, Giorgio La Nasa, et al.
Leukemia|February 23, 2020
The IPSS-R more accurately captures fatigue severity of newly diagnosed patients with myelodysplastic syndromes compared with the IPSS indexFabio Efficace, Francesco Cottone, Laura B Oswald, et al.
Leukemia|September 4, 2019
Health-related quality of life of newly diagnosed chronic myeloid leukemia patients treated with first-line dasatinib versus imatinib therapyFabio Efficace, Fabio Stagno, Alessandra Iurlo, et al.
Cancer|October 6, 2023
Patient-reported symptom monitoring and adherence to therapy in patients with newly diagnosed chronic myeloid leukemiaFabio Efficace, Francesco Cottone, Betina Yanez, et al.
Cancer|December 13, 2017
Patient-reported outcomes enhance the survival prediction of traditional disease risk classifications: An international study in patients with myelodysplastic syndromesFabio Efficace, Francesco Cottone, Gregory Abel, et al.
Pageof 7